Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for OSSUY and 80,000+ other tickers.
See exactly how OSSUY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for OSSUY and 80,000+ other tickers.
Embla Medical hf is an international enterprise focused on orthopedics, dedicated to the innovation, enhancement, production, and worldwide distribution of non-surgical orthopedic solutions. Its business activities are organized across various geographical divisions, including the Americas, the Europe, Middle East, and Africa (EMEA) region, and a unified segment encompassing both the Americas and Asia-Pacific. The company was established in 1971 by Össur Kristinsson and has its primary corporate office situated in Reykjavík, Iceland.
Embla Medical hf. (OSSUY) Q2 2026 Earnings Call Transcript
Embla Medical hf. (OSSUY) Q1 2026 Earnings Call Transcript
Embla Medical hf. (OSSUY) Q4 2025 Earnings Call Transcript
Embla Medical hf. (OTCPK:OSSUY) Q3 2025 Earnings Call October 21, 2025 3:00 AM EDT Company Participants Sveinn Sölvason - President & CEO Gudny Sveinsdottir - Chief Financial Officer Conference Call Participants Jesper Ingildsen - DNB Carnegie, Research Division Tobias Nissen - Danske Bank A/S, Research Division Martin Brenoe - Nordea Markets, Research Division Yiwei Zhou - SEB, Research Division Presentation Operator At this time, I would like to welcome everyone to this Q3 2025 conference call.
Announcement no. 31/2025 17 July 2025 REYKJAVIK, Iceland and COPENHAGEN, Denmark , July 17, 2025 /PRNewswire/ -- Embla Medical (NASDAQ Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today signed an agreement to invest in a majority share (51% of the shares) in privately owned Streifeneder ortho.production GmbH ("Streifeneder").